相关实验视频
Updated: Apr 23, 2026

12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
4.4K
与年龄相关的生育率下降的生育能力保护
Dominic Stoop1, Ana Cobo2, Sherman Silber3
1Centre for Reproductive Medicine, UZ Brussel, Brussels, Belgium.
Lancet (London, England)
|October 7, 2014
概括
使用卵子和卵巢组织冷保存的生育保护为癌症患者和延迟生育的人提供了希望. 成功的分娩证明了这些先进的生殖技术的临床有效性.
科学领域:
- 生殖医学 生殖医学
- 在瘤学瘤学.
- 低温生物学 低温生物学
背景情况:
- 自20世纪中叶以来,癌症患者的生育能力保护一直在探索.
- 卵细胞和卵巢组织的冷保存已经证明了临床成功,特别是在非医疗用途.
- 由于治疗延迟,在使用冷保存卵的癌症患者中报告了有限的怀孕情况.
研究的目的:
- 审查蛋和卵巢组织冷保存的临床成功和应用.
- 评估这些技术对癌症患者和与年龄相关的生育能力下降的潜力.
- 为了突出生育保护策略的进步.
主要方法:
- 对卵子和卵巢组织冷保存的历史和临床数据的审查.
- 对成功怀孕和分娩结果的分析.
- 结冷保存技术的比较及其适用性.
主要成果:
- 由于社会原因,许多健康的孩子从冷保存的卵子中出生.
- 在癌症患者中,超过35名婴儿从冷保存的卵巢组织中出生,他们的生育能力得到恢复.
- 卵巢刺激以获取卵子可以延迟癌症治疗,使卵巢组织冷保存成为可行的替代方案.
结论:
- 卵子和卵巢组织的冷保存是有效的生育保存方法.
- 这些技术对癌症患者和解决与年龄相关的生育率下降有希望.
- 冷保存的进步正在扩大保护生殖潜力的选择.
相关概念视频
Infertility in Females
4.8K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.8K
Infertility in Males
645
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
645
Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Oogenesis
57.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
57.8K
Spermatogenesis
90.4K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
90.4K
Birth Control Methods
5.5K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.5K

